On July 6, Marvell Technology rose 3.36% in pre-market trading, trading at approximately $253.74/share, with turnover of $8.22 million. The stock had previously experienced several consecutive sessions of significant pullback, and this rebound coincided with a broad semiconductor sector recovery.

On the news front, UBS published a research report significantly raising Marvell Technology's target price to $340 from $230, maintaining a Buy rating. The bank is bullish on the company's CXL (Compute Express Link) business growth prospects, projecting CXL-related revenue to reach approximately $20 billion by 2028 and simultaneously raising total revenue forecasts for 2027 and 2028 to $16.8 billion and $23.9 billion, respectively. UBS estimates the global CXL addressable market will reach approximately $4.5 billion by 2027 and expand to $7-10 billion by 2030. The firm also highlighted Marvell's Teralynx T100, a 102.4 Tbps switching chip designed for AI workloads, as a core growth driver.

Within the semiconductor sector, peers also rebounded, with Micron Technology up 3.71%, Intel up 3.65%, and AMD up 3.05%, reflecting broad sector tailwinds supporting the recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)